Skip to main content

Advertisement

SpringerLink
Log in

Thyroid gland

Use of glucocorticoids in amiodarone-induced thyrotoxicosis

  • News & Views
  • Published:

From Nature Reviews Endocrinology

View current issue Sign up to alerts

The incidence of type 2 amiodarone-induced thyrotoxicosis (AIT) is increasing. A new study provides evidence that glucocorticoid therapy is safe, effective and associated with prompt restoration of euthyroidism in previously untreated type 2 AIT. The outcome of initial combined glucocorticoid and thionamide therapy can also help differentiate between type 1 and type 2 AIT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Han, T., Williams, G. R. & Vanderpump, M. P. J. Benzofuran derivatives and the thyroid. Clin. Endocrinol. (Oxf.) 70, 2–13 (2009).

    Article  CAS  Google Scholar 

  2. Martino, E., Bartalena, L., Bogazzi, F. & Braverman, L. E. The effects of amiodarone on the thyroid. Endocr. Rev. 22, 240–254 (2001).

    CAS  PubMed  Google Scholar 

  3. Basaria, S. & Cooper, D. S. Amiodarone and the thyroid. Am. J. Med. 118, 706–742 (2005).

    Article  CAS  PubMed  Google Scholar 

  4. Franklyn, J. A. & Gammage, M. D. Treatment of amiodarone-associated thyrotoxicosis. Nat. Clin. Pract. Endocrinol. Metab. 3, 662–666 (2007).

    Article  CAS  PubMed  Google Scholar 

  5. Tanda, M. L. et al. Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists. Clin. Endocrinol. (Oxf.) 69, 812–818 (2008).

    Article  Google Scholar 

  6. Bogazzi, F. et al. Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort study. J. Clin. Endocrinol. Metab. 94, 3757–3762 (2009).

    Article  CAS  PubMed  Google Scholar 

  7. Bogazzi, F. et al. Glucocoticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. J. Clin. Endocrinol. Metab. 92, 556–562 (2007).

    Article  CAS  PubMed  Google Scholar 

  8. Bogazzi, F. et al. Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy. Clin. Endocrinol. (Oxf.) 67, 533–537 (2007).

    CAS  Google Scholar 

  9. Loy, M. et al. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. Acta Radiol. 48, 628–634 (2007).

    Article  CAS  PubMed  Google Scholar 

  10. Piga, M. et al. The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. Eur. J. Endocrinol. 159, 423–429 (2008).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Royal Free Hampstead NHS Trust, London, UK

    Mark P. J. Vanderpump

Authors
  1. Mark P. J. Vanderpump
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark P. J. Vanderpump.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vanderpump, M. Use of glucocorticoids in amiodarone-induced thyrotoxicosis. Nat Rev Endocrinol 5, 650–651 (2009). https://doi.org/10.1038/nrendo.2009.218

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2009.218

  • Springer Nature Limited

This article is cited by

Search

Navigation